Institute for Wealth Management LLC. Sells 36 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Institute for Wealth Management LLC. cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,563 shares of the company’s stock after selling 36 shares during the period. Institute for Wealth Management LLC.’s holdings in HCA Healthcare were worth $769,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Canoe Financial LP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $41,000. Capital Performance Advisors LLP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $41,000. Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $44,000. Finally, Pinnacle Bancorp Inc. raised its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HCA. KeyCorp lowered their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada reduced their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Trading Down 1.3 %

Shares of NYSE:HCA opened at $330.24 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock has a market cap of $83.65 billion, a PE ratio of 15.03, a P/E/G ratio of 1.12 and a beta of 1.64. The business has a 50 day moving average of $313.23 and a 200-day moving average of $352.96. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 earnings per share. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.91 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is 12.02%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.